Ma Rong, Hu Si-Yuan, Tian Tian, Wei Xiao-Wei, Xiang Xi-Xiong, Ding Ying, Wang Xue-Feng, Chen Yu-Yan
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Apr;34(4):426-30.
To assess the efficacy and safety of Xifeng Zhidong Tablet (XZT) in treating tic disorder children patients of internal disturbance of Gan-wind with phlegm syndrome (IDGWPS).
A stratified randomized, double-blinded, parallel control of placebo, multi-center trial was conducted in 160 subjects from 5 hospitals in China. They were randomly assigned to 2 groups, the test group and the control group, 80 in each group. Those in the test group were treated with XZT, while those in the control group were treated with placebos. The therapeutic course was 4 weeks for all. The effectiveness indicators covered main indicators and secondary indicators. Yale global tic severity scale (YGTSS) was taken as the main indicators. The amelioration of social function impairment, efficacy, single index of Chinese medical syndromes, Chinese medical syndrome efficacy as well as disappearance rate of single Chinese medical symptoms were evaluated as secondary indicators. The safety indicators included clinical adverse events, vital signs, blood/urine/stool routines, renal and liver functions, and electrocardiogram (ECG).
As for main indicators, the score of YGTSS decreased from 22.10 +/- 6.38 to 11.34 +/- 6.58 in the test group, while it decreased from 22.65 +/- 6.70 to 16.82 +/- 6.53 in the control group, showing statistical difference when compared with the same group before treatment (P < 0.01). Besides, the decrement was more significant in the test group after treatment (P < 0.05). As for secondary indicators, the total effective rate was 83.54% in the test group and 34.18% in the controlled group, showing statistical difference between the two groups (P < 0.05). As for social function impairment, 20,38, 16, 3, 1 case(s) in the test group were ranked as normal, minimal, mild, moderate, obvious degree, while 1, 24, 45, 7, and 0 case(s) in the control group were ranked as normal, minimal, mild, moderate, obvious degree. Better effect was obtained in the test group (P < 0.05).As for Chinese medical syndrome efficacy, it was 87.34% in the test group and 64.56% in the control group (P < 0.05). As for single index of Chinese medical syndromes, the disappearance rate of motor tics, irritability, dreaminess, abnormal tongue proper,abnormal tongue fur, and abnormal tongue pulse condition was 78.67%, 34.72%, 62.26%, 34.62%, 58.97%, and 39.74%, respectively in the test group, while they were 34.67%, 13.11%, 21.82%, 15.58%, 25.97%, and 19.48%, respectively in the control group. Better results were shown in the test group (P < 0.05). Totally 5 adverse events occurred. The incidence of adverse events was 3.75% in the test group and 2.53% in the control group.
After 4 weeks of XZT treatment, the integral of YGTSS could be obviously reduced, the degree of social function impairment ameliorated, and Chinese medical syndromes improved. In addition, no adverse reaction occurred in this study.
评价熄风止动片(XZT)治疗小儿抽动障碍肝风内扰挟痰证(IDGWPS)的有效性和安全性。
采用分层随机、双盲、安慰剂平行对照、多中心试验方法,选取我国5家医院的160例患者。将其随机分为2组,试验组和对照组,每组80例。试验组给予熄风止动片治疗,对照组给予安慰剂治疗。疗程均为4周。疗效指标包括主要指标和次要指标。以耶鲁综合抽动严重程度量表(YGTSS)作为主要指标。以社会功能损害改善情况、疗效、中医证候单项指标、中医证候疗效以及中医症状单项消失率作为次要指标。安全性指标包括临床不良事件、生命体征、血/尿/便常规、肝肾功能及心电图(ECG)。
主要指标方面,试验组YGTSS评分由治疗前的22.10±6.38降至11.34±6.58,对照组由22.65±6.70降至16.82±6.53,两组治疗前后比较差异有统计学意义(P<0.01)。且治疗后试验组下降更显著(P<0.05)。次要指标方面,试验组总有效率为83.54%,对照组为34.18%,两组比较差异有统计学意义(P<0.05)。社会功能损害方面,试验组正常、极轻、轻度、中度、重度分别为20、38、16、3、1例,对照组分别为1、24、45、7、0例,试验组效果更好(P<0.05)。中医证候疗效方面,试验组为87.34%,对照组为64.56%(P<0.05)。中医证候单项指标方面,试验组运动性抽动、烦躁、多梦、舌象异常、舌苔异常、脉象异常消失率分别为78.67%、34.72%、62.26%、34.62%、58.97%、39.74%,对照组分别为34.67%、13.11%、21.82%、15.58%、25.97%、19.48%,试验组效果更好(P<0.05)。共发生5例不良事件。试验组不良事件发生率为3.75%,对照组为2.53%。
熄风止动片治疗4周后,可明显降低YGTSS积分,改善社会功能损害程度,改善中医证候。此外,本研究未发生不良反应。